Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-25-005272
Filing Date
2025-07-28
Accepted
2025-07-28 17:00:04
Documents
3
Period of Report
2025-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 8120
2 EX-99.1 betrf_ex991.htm EX-99.1 27225
3 betrf_ex991img6.jpg GRAPHIC 3934
  Complete submission text file 0001477932-25-005272.txt   42125
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)